Difference in awkaening time of cisatracurium-related paralysis with different doses of neostigmine
Not Applicable
- Conditions
- Health Condition 1: K402- Bilateral inguinal hernia, withoutobstruction or gangrene
- Registration Number
- CTRI/2023/07/055639
- Lead Sponsor
- ANSHU KUMARI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA Physical status of I or II
Duration of surgery - 60 mins upto 120 mins.
Exclusion Criteria
1.Refusal to participate in the study
2.Presence of kidney, liver or neuromuscular disease
3.Contraindication to the use of any of the drugs used in the study
4.Body mass index (BMI) >30 kg m-2
5.Viral marker status positive/ COVID
6.Pregnant patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the time required for the reversal of moderate blockade using neostigmine 60 mcg / kg or for reversal of superficial blockade using neostigmine 30 mcg / kgTimepoint: Time of appearance of 1.TOFc 3 <br/ ><br> 2.TOFr 0.4 <br/ ><br> 3.TOFr0.1
- Secondary Outcome Measures
Name Time Method Adverse effects related to neostigmine and glycopyrolate in the post operative periodTimepoint: upto 2hrs postoperatively.